2,859 reports of this reaction
2.9% of all BURN RELIEF reports
#3 most reported adverse reaction
FATIGUE is the #3 most commonly reported adverse reaction for BURN RELIEF, manufactured by Actavis Pharma, Inc.. There are 2,859 FDA adverse event reports linking BURN RELIEF to FATIGUE. This represents approximately 2.9% of all 98,034 adverse event reports for this drug.
Patients taking BURN RELIEF who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for BURN RELIEF, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for BURN RELIEF:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 2,859 FDA reports for BURN RELIEF. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.9% of all adverse event reports for BURN RELIEF, making it one of the most commonly reported side effect.
If you experience fatigue while taking BURN RELIEF, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.